IRP1 mediated ferroptosis reverses temozolomide resistance in glioblastoma via affecting LCN2/FPN1 signaling axis depended on NFKB2

The prognosis of glioblastoma (GBM) patients is poor, and temozolomide (TMZ) resistance has become an important obstacle to its treatment effect. A growing number of researches have revealed the special characteristics of iron metabolism in GBM chemosensitivity. Iron regulatory protein 1 (IRP1) is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Yufei, Yang, Tao, Yue, Qu, Wang, Zhao, Zhong, Xiangyang, Luo, Xin, Zuo, Boming, Zhang, Manqing, Zeng, Tianci, Liu, Boyang, Guo, Hongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374607/
https://www.ncbi.nlm.nih.gov/pubmed/37520713
http://dx.doi.org/10.1016/j.isci.2023.107377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374607/
https://www.ncbi.nlm.nih.gov/pubmed/37520713
http://dx.doi.org/10.1016/j.isci.2023.107377

Ejemplares similares